Document:

EX-10.1

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF ILLINOIS

EASTERN DIVISION

	 	 	 	 	 
	 

	 	 
	 	 
	UNITED STATES OF AMERICA

	 	 
	 	No.
	v.

	 	 
	 	 
	LAWSON PRODUCTS, INC.

	 	 
	 	Judge

AMENDMENT NO. 1 TO DEFERRED PROSECUTION AGREEMENT

Defendant LAWSON PRODUCTS, INC. (“LAWSON PRODUCTS”), a company headquartered in Des Plaines,
Illinois, by its undersigned attorneys, pursuant to authority granted by its Board of Directors,
and the UNITED STATES OF AMERICA, through PATRICK J. FITZGERALD, United States Attorney for the
Northern District of Illinois, enter into this Amendment No. 1 dated July 31, 2009 to Deferred
Prosecution Agreement (this “Amendment”), which shall apply to LAWSON PRODUCTS and all its
affiliates and subsidiaries, including Drummond American Corporation and Cronatron Welding Systems,
Inc. and which amends the Deferred Prosecution Agreement (the “Agreement”) dated as of August 11,
2008.

1. Paragraph 2 of the Agreement is hereby amended and restated to read in its entirety as
follows:

“3. LAWSON PRODUCTS agrees to place a total of $30,000,000 in an escrow account to
fund the payment of restitution and a civil forfeiture judgment as further set forth below.
LAWSON PRODUCTS shall make the first $10,000,000 payment on or before the date that LAWSON
PRODUCTS executes this Agreement. LAWSON PRODUCTS shall make a $5,000,000 payment on or
before August 15, 2009 and a further $5,000,000 payment on or before December 31, 2009.
LAWSON PRODUCTS shall make its final $10,000,000 payment on or before August 11, 2010. At
any point, should a controlling interest in LAWSON PRODUCTS be sold, the remaining payments
shall be accelerated and due at the closing of that sale.”

2.  This Amendment shall be considered an amendment to and a part of the Agreement.

3.  Except as specifically stated herein, all terms, covenants and conditions of the Agreement
shall remain in full force and effect.

1

AGREED:

For LAWSON PRODUCTS:

	 	 	 	 	 	 	 	 	 
	
 
	 	 
	 	 	 	 
	 	 
	/s/ Thomas J. Neri

 

THOMAS J. NERI

	 	 
	 	/s/ William D. Heinz

 

WILLIAM D. HEINZ
	 	

 
	 	

 
	President and Chief

Executive Officer

	 	

 
	 	

Jenner & Block LLP
	 	

 
	 	

 
	Lawson Products, Inc.

	 	 
	 	Counsel for Lawson Products, Inc.
	 	 
	 	 
	 

	 	 
	 	 
	 	 
	 	 
	For the UNITED STATES OF

AMERICA:

	 	

 
	 	

 
	 	

 
	 	

 
	
 
	 	 
	 	 	 	 
	 	 
	/s/ Patrick J. Fitzgerald

 

PATRICK J. FITZGERALD

	 	 
	 	/s/ Brandon D. Fox

 

BRANDON D. FOX
	 	

 
	 	

 
	United States Attorney

	 	 
	 	NANCY MILLER
	 	 
	 	 
	 

	 	 
	 	KRUTI TRIVEDI
	 	 
	 	 
	 

	 	 
	 	Assistant United States Attorneys
	 	 
	 	 

2EX-10.1

AMENDMENT TO PROMISSORY NOTE, LOAN AGREEMENT, MORTGAGE

AND LOAN DOCUMENTS AND ASSUMPTION AND LOAN MODIFICATION

AGREEMENT

THIS AMENDMENT TO PROMISSORY NOTE, LOAN AGREEMENT, MORTGAGE AND LOAN DOCUMENTS AND ASSUMPTION
AND LOAN MODIFICATION AGREEMENT (hereinafter the “Amendment”) made and entered into as of the
31st day of July, 2009 by and between Commerce Bank & Trust Company, a Massachusetts
trust company with a principal place of business at 386 Main Street, Worcester, Massachusetts
(hereinafter “Lender”) and Seracare Life Sciences, Inc., a Delaware corporation having its
principal place of business at 37 Birch Street, Milford, Massachusetts 01757 (hereinafter
“Borrower”) is firmly affixed to and made a part of a certain Promissory Note of Boston Biomedica,
Inc. payable to the order of the Lender dated as of March 31, 2000 in the original principal amount
of Two Million Nine Hundred Thousand and 00/100 Dollars ($2,900,000.00), and assumed by the
Borrower as of September 14, 2004 and having a current principal balance of $1,823,973.11
(hereinafter “Note”).

WHEREAS, the Borrower did enter into and execute a certain Assumption and Modification
Agreement in favor of the Lender, dated September 14, 2004 (hereinafter the “Assumption Agreement”)
in which the Borrower agreed to assume each and every obligation of Boston Biomedica, Inc. to the
Lender as defined and described in the Loan Documents as defined and modified under that certain
Assumption Agreement; and,

WHEREAS, the Borrower and the Lender wish to further amend, renew and affirm the Loan
Documents and Assumption Agreement and certain conditions therein.

FOR GOOD AND VALUABLE CONSIDERATION, the receipt and sufficiency of which are hereby
acknowledged, including the Lender’s continuing extension of credit to the Borrower, the Borrower
and the Lender hereby agree that the Loan Documents are amended as follows:

	 	 	 	1. Borrower will reduce the outstanding principal balance to $1,200,000.00 by
direct payments to principal resulting in the following outstanding principal balances
on or before the first (lst) business day of each month as stated:

	 	•	 	$1,600,000.00 August 2009

	 	•	 	$1,400,000.00 September 2009

	 	•	 	$1,200,000.00 October 2009

	 	2.	 	Interest Rate to be established at the Commerce Bank Base Rate plus 300 basis
points, fully floating with a floor of 6.25%.

	 	3.	 	Extension fee of $18,000.00 payable on, or before execution of modification
documents.

	 	4.	 	Maturity: Eighteen (18) months from the date of execution herein or no later
than February 28, 2011.

	 	5.	 	Payments of Interest as billed for months of August 2009, September 2009, and
October 2009, with monthly payments of Principal and Interest based on a ten (10) year
amortization schedule of the scheduled reduced principal balance of $1,200,000.00 at
the applicable Interest Rate beginning November 1, 2009.

	 	6.	 	Prepayment of principal in any amount allowed at any time without penalty.

	 	7.	 	Incremental principal reductions shall be made in amounts equal and
simultaneous to the amount of any reduction in the market listing price.

	 	8.	 	Borrower will submit complete and current disclosure of on-going property
marketing activity including detail of all listing terms and prospect inquiries.

	 	9.	 	Borrower will maintain a minimum net worth of $18,000,000.00 at all times.

	 	10.	 	All references in the Loan Documents delivered in connection therewith shall
be deemed to mean the Note as amended by this Amendment.

As hereby amended, the Note is hereby ratified and confirmed in all respects, and all terms
and provisions of the Note not amended hereby shall remain in full force and effect.

WITNESS THE EXECUTION HEREOF, as an instrument under seal as of the date first set forth
above.

	 	 	 
	 	 	SERACARE LIFE SCIENCES, INC.
	                               
	 	

	     
	 	

	 	 	/s/ Susan L.N. Vogt

	 	 	 

	 	 	By: Susan L.N. Vogt

	 	 	Its: President

	 	 	 

	 	 	 

	 	 	/s/ Gregory A. Gould

	 	 	 

	 	 	By: Gregory A. Gould

	 	 	Its: Chief Financial Officer/

	 	 	Treasurer/Secretary

	 	 	 

	 	 	 

	 	 	COMMERCE BANK & TRUST COMPANY

	  
	 	

	  
	 	

	 	 	/s/ Paul E. Lesniewski

	 	 	 

	 	 	By: Paul E. Lesniewski

	 	 	Its: Senior Vice President

COMMONWEALTH OF MASSACHUSETTS

Worcester                                                                     ss.

On this 29 day of July, 2009 before me, the undersigned notary public, personally appeared
Susan L.N. Vogt, proved to me through satisfactory evidence of identification, which was
photographic identification with signature issued by a federal or state governmental agency, oath
or affirmation of a credible witness, personal knowledge of the undersigned, to be the person whose
name is signed on the preceding document, and acknowledged to me that he/she signed it voluntarily
for its stated purpose as President of Seracare Life Sciences, Inc.

	 	 	 
	                                                         
	 	Notary Public: /s/ Shannon M. Galvin

	 	 	Commission Expires: February 21, 2014

COMMONWEALTH OF MASSACHUSETTS

Worcester                                                                      ss.

On this 21 day of July, 2009 before me, the undersigned notary public, personally appeared
Gregory A. Gould, proved to me through satisfactory evidence of identification, which was
photographic identification with signature issued by a federal or state governmental agency, oath
or affirmation of a credible witness, personal knowledge of the undersigned, to be the person whose
name is signed on the preceding document, and acknowledged to me that he/she signed it voluntarily
for its stated purpose as Chief Financial Officer/Treasurer/Secretary of Seracare Life Sciences,
Inc.

	 	 	 
	                                                          
	 	Notary Public: /s/ Shannon M. Galvin

	 	 	Commission Expires: February 21, 2014

 

COMMONWEALTH OF MASSACHUSETTS

Worcester                                                                      ss.

On this 31st day of July, 2009 before me, the undersigned notary public, personally appeared
Paul E. Lesniewski, proved to me through satisfactory evidence of personally known identification,
which was personal knowledge of the undersigned, to be the person whose name is signed on the
preceding document, and acknowledged to me that he/she signed it voluntarily for its stated purpose
as SVP of Commerce Bank & Trust Company.

	 	 	 
	                                                          
	 	Notary Public: /s/ Lucile E. Daly

	 	 	Commission Expires: Feb. 25, 2016EX-10.1

INTRODUCTION

This guide provides a summary of Corinthian Colleges, Inc.’s (the company) Executive Bonus Plan
(the plan), for July 1st, 2009 – June 30th, 2010 (plan term).

The plan provides a lump-sum cash payment following the completion the fiscal year for achievement
of annual budgeted operating profit and other goals based on predetermined performance and award
schedules.

ELIGIBILITY

Current Employees

For a current employee in a position to be eligible, the employee must be employed in a
bonus-eligible position on the first day of the plan term and remain employed by the company on the
payment date.

New Hires, Promotions and Transfers

If an employee starts in a bonus eligible position after the start of the fiscal year (new hire or
employee moving from no bonus plan to this bonus plan), the employee is eligible for a bonus on the
first day of the next month following their start date, promotion date or transfer date. Annual
overachievement bonus will be based on the company’s performance over the full fiscal year but the
employee’s bonus will be prorated based on the number of full months the employee was in the
position.

	 	 	 	Example: If an employee is hired on February 3rd, 2010, his or her proration
would be for 4 full months of service (March, April, May and June).

Any time an employee moves from an annual plan to a quarterly plan (or a quarterly plan with an
annual overachievement), the employee begins eligibility in the new plan on the first day of the
next fiscal quarter, and remains eligible under the old plan up until that date.

Any time an employee moves from a quarterly plan (or a quarterly plan with an annual
overachievement) to an annual plan, the employee begins eligibility in the new plan on the first
day of the next fiscal quarter, and remains eligible in the old plan up until that date.

Circumstances not fitting into the above criteria will be determined on a case by case basis by the
Chief Executive Officer and Human Resources.

Terminations or Resignations

Any employee who leaves the company for any reason before the payment date will not be eligible to
receive a bonus.

Leave of Absences

A bonus eligible employee absent from work for any consecutive period greater than 30 days will
receive a pro-rated bonus based on number of full months worked in the quarter or year. Example:
If the employee is absent from February 15th to March 25th, the employee
would receive a quarterly bonus pro-rated to 1 month (January was the only full month worked in the
quarter) and a annual bonus pro-rated to 10 months.

PLAN COMPONENTS, MEASURES AND MECHANICS

Please see the accompanying document(s) for details pertaining to the components, measures and
specific mechanics for your plan.

If applicable in your Bonus Plan Schedule, during the first quarter of the plan term, you will work
with your supervisor to develop your Management Bonus Objectives (MBOs) for this bonus plan.

GATES

All gates for the annual payouts must be achieved to qualify for any payout whatsoever.

AWARD DETERMINATION AND SIZE OF AWARD

The plan operates under a “target award” framework, where participants have a bonus target as a
percentage of base pay, and earn awards based on the degree to which performance goals are
achieved.

The award calculation is based on a percentage of a participant’s annual base salary in effect at
the end of the plan term.

PAYMENT DATE

Payouts earned will be paid up to 90 days following the end of the plan term.

OTHER INFORMATION

The company reserves the right to suspend, modify or terminate this plan at any time in the sole
discretion of its Board of Directors (the “Board”). For example, the company may reduce, suspend,
modify or eliminate the payment of any quarterly bonus earned if significant regulatory and/or
business practices are found to be out of compliance by the company’s Board.

The company also reserves the right to adjust bonus plan performance targets upon the occurrence of
unusual or extraordinary events in the sole discretion of the Board. Nothing in this document is
to be construed to guarantee its continuation in this or any future year or guarantee any
employee’s participation in the plan.

The Board will make the final decision regarding any disputed bonus computation or award.

	 	 	 
	PLAN APPROVAL	 	 
	Corporate Human Resources

	 	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]